✍ Scribed by Philipp N. Baecker, Prof. Ulrich Hommel (auth.), Prof. Dr. Thomas Dangl, Prof. Dr. Michael Kopel, Prof. Dr. Wolfgang Kürsten (eds.)
No coin nor oath required. For personal study only.
Dr.Thomas Dangl ist Ao.Univ.-Prof. am Institut für Managementwissenschaften der Technischen Universität Wien.
Dr. Michael Kopel ist ebenfalls Ao.Univ.-Prof. Universitätsdozent am Institut für Managementwissenschaften an der Technischen Universität Wien.
Prof. Dr. Wolfgang Kürsten ist Inhaber des Lehrstuhls für allgemeine Betriebswirtschaftlehre, insbesondere Finanzierung, Banken und Risikomanagement an der Friedrich Schiller-Universität Jena.
Front Matter....Pages N2-X
25 Years Real Options Approach to Investment Valuation: Review and Assessment....Pages 1-54
Accounting-based Investment Incentives and Real Options....Pages 55-76
The Evaluation of Venture Capital as an Instalment Option: Valuing Real Options Using Real Options ....Pages 77-96
Strategic Investment under Uncertainty: Merging Real Options with Game Theory....Pages 97-124
Closure Options in a Duopoly with Strong Strategic Externalities....Pages 125-157
Back Matter....Pages 158-159
Finance/Investment/Banking
📜 SIMILAR VOLUMES
Praise for Real Options Analysis <P>"This book is a must-have and must-read . . . Mun’s new book is a refreshing, cutting-edge look at a powerful new decision-making process . . . it isn’t often you can truthfully say a book breaks new ground, but [this book] has certainly done that." –Gl
Real options theory has attracted significant interest in the field of strategic management. Advocates of the approach emphasize that importing concepts from financial economics holds out the potential of yielding new insights on strategic decision-making under uncertainty as well as boundary-of-th
<p><p>This book explains the standard Real Options Analysis (ROA) literature in a straightforward, step by step manner without the use of complex mathematics. A lot of ROA literature is described through partial differential equations, probability density functions and simulation techniques, all of
How much should a pharmaceutical company invest in R&D for a new drug? <P>At what point do the costs outweigh the benefits of a new technology? <P>When should you abandon that oil-drilling project? <P>''Real options is an exciting but very challenging subject for many strategy and cor
How much should a pharmaceutical company invest in R&D for a new drug? <P>At what point do the costs outweigh the benefits of a new technology? <P>When should you abandon that oil-drilling project? <P>"Real options is an exciting but very challenging subject for many strategy and corp
<p><P><STRONG>OR Society Award 2008!</STRONG></P><P><STRONG>For his excellent monograph, Rainer Brosch won the German OR Society Award 2008 for outstanding theses in the field of Operations Research in September 2008.</STRONG></P><P>"Valuing portfolios of options embedded in investment decisions is